A Study of Single Dose of ABT-333 in Healthy Male Adults
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objectives of this study is to assess the safety, tolerability, and pharmacokinetics of
blind, escalating, single, oral doses of ABT-333 under nonfasting conditions in healthy male
adult in Japan.